A former chronic pain sufferer, Court Wing is the founder and CEO of REMAP Therapeutics and a co-founder of the Psychedelics & Pain Association. REMAP Therapeutics is devoted to the development of formal psychedelic rehabilitation sessions and cohesive best practices for many treatment-resistant chronic pain conditions. Court is an accomplished performance and pain professional with over 14 years of formal Ki-Aikido study and 30 years of experience in maximizing the athletic performance of his clients, helping countless individuals overcome injury to return to competition and daily life. He is a certified Z-Health Master Trainer and

was co-founder of CrossFit NYC.

In 2020, Court was a study participant in NYU’s clinical trial of Psilocybin for Major Depressive Disorder. By the end of his “dosing” day in the trial, he was in full remission, no longer qualifying for the diagnosis of depression. More astounding were the lateral benefits; he was also no longer suffering from low-to-moderate chronic pain and related neurological issues from previous injuries. Court’s commitment to further investigate the healing potential of psychedelics stems from his direct experience as a participant in this psilocybin trial. With his extensive experience in applied neurophysiology for pain & performance, he immediately realized psychedelics were going to completely change the way we

are able to treat chronic pain.

Links and socials:

REMAP Therapeutics: https://remaptherapeutics.com

Psychedelics & Pain Association (PPA): https://psychedelicsandpain.org

www.courtwing.com

Twitter: @remaptherapy

Insta: @remaptherapeutics

Facebook: REMAP Therapeutics

LinkedIn: REMAP Therapeutics

Links mentioned:

Vox article: Psychedelics could treat some of the worst chronic pain in the world

Chronic Pain & Psychedelics study

1962 study on Psychedelics and Phantom Limb pain

ClinicalTrials.gov